Epidemiology of Pathogens and Antimicrobial Resistance
A special issue of Antibiotics (ISSN 2079-6382). This special issue belongs to the section "Antibiotic Therapy in Infectious Diseases".
Deadline for manuscript submissions: closed (30 September 2024) | Viewed by 6863
Special Issue Editor
Special Issue Information
Dear Colleagues,
Since the advent of penicillin in the 1940s, we have been at war with microorganisms, each trying to outcompete the other for survival. As we have produced new antibiotics to combat increasing resistance, bacteria have also been developing new ways to evade these agents. A significant challenge for clinicians, especially when facing drug-resistant pathogens, is whether the isolated pathogen is colonizing or infecting the patient. The overtreatment of pathogens occurs due to this challenge, and leads to the development of further antimicrobial resistance. Therefore, it is imperative to benchmark infecting and colonizing pathogens, as well as their resistance mechanisms, which offers a starting point for determining appropriate antimicrobial use within health systems.
The aim of this Special Issue is to allow readers to understand the relationship between antimicrobial resistance, antimicrobial use, and the epidemiology of pathogens around the world. Submissions of all types, including original research, brief reports, reviews, or short communications are welcome. In addition, the submission of resident or trainee research projects that focus on identifying antimicrobial resistance and local pathogen identification in hospitalized patients is also welcomed.
Dr. Jamie Wagner
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Antibiotics is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- epidemiology
- pathogens
- antimicrobial resistance
- antimicrobial stewardship
- multidrug-resistance
- benchmarking
- colonization
- infection
- health-systems
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.